These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2956000)

  • 21. The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report.
    Sterodimas A; Vargas A; Radwanski HN; Pitanguy I
    Aesthetic Plast Surg; 2008 Mar; 32(2):383-5. PubMed ID: 18058164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of retinal vascular diseases by an arterioleptic. Eucilat (5-benzofuran derivative)].
    Chermezon JP; Cauny M
    Arch Ophtalmol Rev Gen Ophtalmol; 1972 Oct; 32(10):653-60. PubMed ID: 4267678
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P; Pagratis N
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F; Capecchi PL; Acciavatti A; Petri S; de Lalla A; Cati G; Colafati M; Di Perri T
    Clin Hemorheol Microcirc; 1997; 17(1):73-84. PubMed ID: 9181761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L; Gandolfo AM; Utz C
    MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R; Klaus D
    Vasa; 1984; 13(2):171-4. PubMed ID: 6741240
    [No Abstract]   [Full Text] [Related]  

  • 28. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
    Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C
    J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reaction of the conjunctival and retinal vessels to the administration of vasodilators to patients with vascular disorders of the fundus oculi].
    Davydova NG; Bunin AIa; Nikol'skaia VV; Lysenko VS; Iakovleva AA
    Vestn Oftalmol; 1985; 101(3):38-40. PubMed ID: 4035869
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study.
    Ducrey N; Curchod B
    J Int Med Res; 1984; 12(3):184-7. PubMed ID: 6734921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
    Demichelis Genesio MA; Sanz MC
    Angiology; 1981 Oct; 32(10):717-28. PubMed ID: 7034593
    [No Abstract]   [Full Text] [Related]  

  • 33. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
    De Martiis M; Parenzi A; Barlattani A; De Martiis A
    Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
    [No Abstract]   [Full Text] [Related]  

  • 34. [The combination of repeated anesthetic "bathing" of the cervico-thoracic system and buflomedil in analgesic therapy of in Raynaud's syndrome of the arm].
    Bonezzi C; Navazio Cassa G; Sangiovanni G; Brambilla GL
    Minerva Cardioangiol; 1985 Oct; 33(10):655-7. PubMed ID: 4080170
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study].
    Minerva Med; 1985 Oct; 76(39):1803-11. PubMed ID: 4047463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Edematous maculopathies and piribedil].
    Jayle GE; Metge P
    Annee Ther Clin Ophtalmol; 1972; 23():363-98. PubMed ID: 4680289
    [No Abstract]   [Full Text] [Related]  

  • 38. [Selected problems of conservative treatment of retinal diseases].
    Kozuchowska I
    Klin Oczna; 1973 Feb; 43(2):135-40. PubMed ID: 4805030
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of long-term administration of buflomedil on regional cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Okada K; Kitani M; Yamashita K; Shimote K; Tsunematsu T
    Angiology; 1988 Nov; 39(11):934-41. PubMed ID: 3177960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.